Chronic obstructive pulmonary disease (COPD) is a complex, heterogeneous disease. Management of patients with COPD has been complicated by evolving clinical guidelines that incorporate novel escalation strategies with dual long-acting ß agonist (LABA)/long-acting muscarinic antagonist (LAMA) bronchodilation treatments, and LAMA/LABA/inhaled corticosteroid (ICS) triple therapy. Dual bronchodilation and triple therapy treatment options are both now available as fixed-dose combination inhalers. Despite updated recommendations, there is limited practical guidance on individualizing therapy or identifying patients who may benefit from treatment escalation. In addition, lack of knowledge of appropriate COPD inhaler use and self-management strategies persist among patients and caregivers, precluding optimal therapeutic benefit and clinical outcomes. This live broadcast educational activity will feature 3 international experts in COPD who will review and discuss the clinical science behind dual-bronchodilation therapy, advances in triple therapy, and the new COPD recommendations, as well as implementation of practical individualized treatment and inhaler strategies for patients with COPD.
This goal of this activity is for physicians, physician assistants, nurse practitioners, and nurses who manage patients with COPD in pulmonology settings to develop the knowledge base to incorporate dual- and triple-bronchodilation management strategies into their practice, based on guideline recommendations, and to improve individualized treatment plans for their patients with COPD.